SecBot SecBot
8-K ·Filed Nov 9, 2026

SHFS

SHF Holdings, Inc.
BEARISH
Impact 7/10
Horizonimmediate Processed7d 18h ago SEC0001493152-26-050636
8-K Item 2.02: Earnings release
Actionable Insight ▼ Bearish

Watch for the Abaca litigation ruling (potential $7.8M liability exceeding available cash), further Series B conversions that could push shares outstanding above 195M, and whether the stock closes below $0.10 for two more consecutive days triggering Nasdaq delisting. The Opifex deal is highly conditional and non-binding; any definitive agreement will require stockholder vote and Nasdaq approval.

DirectionBearish
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

Executive Summary

SHF Holdings (Safe Harbor) reported Q3 2026 revenue of $1.95M (+6.5% YoY) and a net loss of $979,000, swinging from net income of $180,000 in Q3 2025 due to a prior-year debt extinguishment gain. The core business showed modest growth in loan program income (+70.2%) and client deposits, but the filing is dominated by severe capital structure distress: massive dilution from Series B preferred conversions (shares outstanding surged from 1.03M to 132.25M), a going concern disclosure, Nasdaq delisting risk (stock closed below $0.10 for 8 consecutive days), and a proposed reverse-merger with Opifex that would leave existing holders with only ~15% of the combined entity.

Key Financial Metrics

EPS
−$0.95
Revenue
$1.9M
+6.5% YoY

Key Facts

  • Q3 2026 revenue $1.95M, +6.5% YoY from $1.83M
  • Net loss $979,000 vs net income $180,000 in Q3 2025 (prior year included $3.34M debt extinguishment gain)
  • Operating loss narrowed 17.7% to $1.0M from $1.22M
  • Loan program income +70.2% to $869,000 on improved revenue-sharing with PCCU
  • Shares outstanding exploded from 1,028,702 on Sept 30 to 132,248,520 on Nov 6 due to Series B conversions at $0.1210/share
  • 7,605 Series B shares remain, convertible into up to 62.9M additional common shares
  • Stock closed below $0.10 for 8 consecutive days; Nasdaq delisting possible before April 19, 2027 compliance deadline
  • Going concern disclosure in unaudited financial statements
  • Non-binding term sheet with Opifex for reverse merger; existing SHFS holders would get ~15% of combined company
  • Cash and cash equivalents $4.4M as of Sept 30, down from $6.78M at Dec 31, 2025
  • Operating cash flow -$4.05M for nine months 2026 vs -$2.35M prior year
  • Abaca litigation trial held Aug 10-11, 2026; court ruling pending; estimated loss range $0-$7.8M

Financial Impact

Massive dilution: common shares outstanding increased 128x from 1.03M to 132.25M in two weeks. Remaining Series B convertible preferred could add another 62.9M shares. Cash burn continues with $4.05M operating cash outflow YTD. Proposed Opifex deal would dilute legacy holders to ~15% ownership.

dilutioncash positionoperating cash flownet lossshare count

Risk Factors

  • Imminent Nasdaq delisting if stock closes below $0.10 for 2 more consecutive days (8 of 10 days already met)
  • Further dilution from remaining 7,605 Series B shares convertible into 62.9M common shares
  • Abaca litigation adverse ruling could exceed available liquidity ($4.4M cash vs $7.8M potential loss)
  • Proposed Opifex reverse merger may not close; existing holders face 85% dilution even if it does
  • Going concern uncertainty; negative operating cash flow and limited financing options
  • Equity line of credit not being drawn while Opifex term sheet is in effect, limiting liquidity

Market Snapshot

Exchange
Nasdaq
Sector
Finance Services
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-050636
Exhibit: ex99-2.htm0001493152-26-050636
Document: form8-k.htm0001493152-26-050636
Document: 0001493152-26-050636-index-headers.html0001493152-26-050636
Document: 0001493152-26-050636-index.html0001493152-26-050636
Document: 0001493152-26-050636.txt0001493152-26-050636
8-K Data (Synthetic)0001493152-26-050636

Track record

27 reports on SHFS

Performance horizon

13 of 16 bullish or bearish reports moved the stock their way by T+5. Best: +98.49% at T+60 after the Aug 11, 2026 report. 16 of 18 went positive at some point.

Filters
  1. Nov 13, 20263d ago S-1 Bearish 7/10 Entry $0.0277 Now $0.0230 +16.97% settles Nov 23
  2. Nov 13, 20263d ago DEFA14A Bearish 7/10 Entry $0.0280 Now $0.0230 +17.86% settles Nov 23
  3. Nov 12, 20264d ago 425 Bearish 7/10 Entry $0.0303 Now $0.0230 +24.09% settles Nov 20
  4. Nov 12, 20264d ago 8-K Bearish 9/10 Entry $0.0303 Now $0.0230 +24.09% settles Nov 20
  5. Nov 9, 20267d ago DEFA14A Bearish 7/10 Entry $0.0248 to $0.0230 Now $0.0230 +7.26% ▲ +7.26% +5.57% vs SPY
  6. Nov 9, 20267d ago 425 Bearish 7/10 Entry $0.0248 to $0.0230 Now $0.0230 +7.26% ▲ +7.26% +5.57% vs SPY
  7. Nov 9, 20267d ago 8-K Bearish 7/10 Viewing No price data
  8. Nov 9, 20267d ago Press Release Bearish 7/10 Entry $0.0248 to $0.0230 Now $0.0230 +7.26% ▲ +7.26% +5.57% vs SPY
  9. Nov 9, 20267d ago Press Release Bearish 7/10 Entry $0.0248 to $0.0230 Now $0.0230 +7.26% ▲ +7.26% +5.57% vs SPY
  10. Oct 30, 202617d ago 8-K Bearish 7/10 Entry $0.0462 to $0.0248 Now $0.0230 +50.22% ▲ +46.32% +46.40% vs SPY
Showing 10 of 27

US Market Status

Market Closed · Opens in 7h 11m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026